You just read:

Bausch + Lomb Announces FDA Approval Of LOTEMAX® SM (loteprednol Etabonate Ophthalmic Gel) 0.38% For The Treatment Of Postoperative Inflammation And Pain Following Ocular Surgery

News provided by

Bausch Health Companies Inc.

Feb 25, 2019, 07:00 ET